Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Salix Pharmaceuticals, Ltd. announced the U.S. Food and Drug Administration has granted marketing approval for METOZOLV™ ODT 5mg and 10mg orally disintegrating tablets. METOZOLV ODT is indicated for the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis and for the treatment of short–term therapy for adults with symptomatic documented gastroesophageal reflux disease who fail to respond to conventional therapy.

Today in Drug Approvals...keeping you current

ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09

Human genome sciences receives complete response letter from fda for raxibacumab biologics license application
Human Genome Sciences, 11/17/09

Panenza, Sanofi Pasteurs Influenza A(H1N1) 2009 Vaccine, Approved in France
Sanofi-aventis, 11/17/09

Today in Stomach/GI...keeping you current

Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter OATP2A1 expressed in human gastroduodenal mucosa
Journal of Pharmacology and Experimental Therapeutics, 11/20/09

Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy
Infection, 11/19/09

The Helicobacter pylori Mfd protein is important for antibiotic resistance and DNA repair
Diagnostic Microbiology and Infectious Disease, 11/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address